Clinical trial

Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis

NCT05340985

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-07-01

PhasePHASE4

Study timeline

Study start (estimated)2022-07-01Date precision: month

Registry last updated2022-04-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosis, Relapsing-Remittingunresolved

Adult ALLunresolved

Vitamin D3 Deficiencyunresolved

Interventions

25(OH)D3DIETARY_SUPPLEMENT

vitamin D3DIETARY_SUPPLEMENT

Sponsors & collaborators

Tehran University of Medical Scienceslead sponsor

Boston Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05340985 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.